VYNE Therapeutics (VYNE) Earnings Analysis
VYNE Therapeutics (VYNE) next reports earnings on 2026-08-13, consensus EPS -0.18 USD. Last quarter (2026-05-14) it beat with EPS -0.0838 USD vs -0.18 USD est (+53.4%). It has beaten estimates in 4/7 recent quarters (57%). Trailing P/E -1.86.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does VYNE next report earnings?
| Next earnings date | 2026-08-13 |
|---|---|
| Consensus EPS estimate | -0.18 USD |
| Revenue estimate | 0.00B |
VYNE earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-05-14 | -0.0838 USD | -0.18 USD | +53.4% | Beat |
| 2026-03-12 | -0.28 USD | -0.2 USD | -40% | Miss |
| 2025-11-06 | -0.17 USD | -0.19 USD | +10.5% | Beat |
| 2025-08-14 | -0.13 USD | -0.23 USD | +43.5% | Beat |
| 2025-03-06 | -0.28 USD | -0.31 USD | +9.7% | Beat |
| 2024-11-07 | -0.29 USD | -0.24 USD | -20.8% | Miss |
| 2024-08-14 | -0.22 USD | -0.19 USD | -15.8% | Miss |
Beat rate: 4/7 (57%) over reported quarters with consensus data.
VYNE valuation and analyst view
| Trailing P/E | -1.86 |
|---|---|
| Trailing EPS | -0.50171 USD |
| Price / book | 1.56 |
| Dividend yield | 42.34% |
| Market cap | 0.01B |
| Analyst consensus | Buy (1 buy / 1 hold / 0 sell) |
Related research pages
Frequently asked questions
When is VYNE Therapeutics (VYNE)'s next earnings date?
VYNE Therapeutics is next scheduled to report on 2026-08-13, with a consensus EPS estimate of -0.18 USD and revenue estimate of 0.00B.
Did VYNE beat earnings last quarter?
In its 2026-05-14 report, VYNE posted EPS of -0.0838 USD versus a -0.18 USD estimate — a beat of 53.4%.
What is VYNE's earnings track record?
Over the last 7 reported quarters with consensus data, VYNE beat estimates 4 times (57%).
What is VYNE's current P/E ratio and EPS?
VYNE trades at a trailing P/E of -1.86 on trailing EPS of -0.5017068836513281 USD.
What do analysts rate VYNE?
Analyst consensus is "Buy" across 2 ratings (0 strong buy, 1 buy, 1 hold, 0 sell, 0 strong sell).